Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
February 08, 2024
While labor market impacts of refugees in low- and middle-income countries are commonly studied, public services like education could also be affected by mass arrivals. This paper examines the impact of Syrian refugees on the educational outcomes of Jordanians. Combining detailed household surveys w...
Blog Post
November 08, 2023
How stable do emerging markets look now, in 2023? Which countries would be most and least resilient if another global adverse shock were to happen? A simple indicator constructed from a small set of economic and institutional variables was able to identify in 2019, prior to the COVID-19 pandemic and...
POLICY PAPERS
January 19, 2023
The Middle East and North Africa (MENA) is addicted to fossil fuels, like the rest of the world. An energy transition will require a coordinated global shift in both the supply and demand for fossil fuels and cleaner energy, and multilateral institutions can play an important role. These institution...
Blog Post
January 19, 2023
The Middle East and North Africa (MENA) is addicted to fossil fuels but so too is the rest of the world. An energy transition will require a coordinated global shift in both the supply and the demand for fossil fuels and clean(er) energy, and multilateral institutions can play an important role.
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
Blog Post
November 28, 2022
Building on the success of Operation Warp Speed, the US should deepen its engagement and ambition in global health R&D to drive transformative improvements in global health outcomes and security. Specifically, it should consider a subscription model for new antimicrobials; an advance market commitme...